Skip to content
10-Q

Quarterly Report

MOLECULAR PHARMACOLOGY (USA) LTD.

0001221508-14-000024

← back to feed
Filed
Nov 13, 2014 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q1 2015 · Nov 12, 2014 111.55M sh
Operating Cash Flow Q1 2015 · Sep 30, 2014 −$32.28K
Operating Cash Flow Q1 2015 · Sep 30, 2014 −$2.22M
Operating Cash Flow Q1 2015 · Sep 30, 2013 −$28.34K
Cash And Equivalents Q1 2015 · Sep 30, 2014 $1.52K
Cash And Equivalents Q1 2015 · Jun 30, 2014 $2.38K
Stockholders Equity Q1 2015 · Sep 30, 2014 −$2.1M
Stockholders Equity Q1 2015 · Jun 30, 2014 −$2.23M
Current Liabilities Q1 2015 · Sep 30, 2014 $2.11M
Current Liabilities Q1 2015 · Jun 30, 2014 $2.24M
Current Assets Q1 2015 · Sep 30, 2014 $8.84K
Current Assets Q1 2015 · Jun 30, 2014 $8.97K
Net Income Q1 2015 · Sep 30, 2014 −$29.03K
Net Income Q1 2015 · Sep 30, 2014 −$2.21M
Net Income Q1 2015 · Sep 30, 2013 −$40.77K
Operating Income Q1 2015 · Sep 30, 2014 −$28.93K
Operating Income Q1 2015 · Sep 30, 2014 −$2.49M
Operating Income Q1 2015 · Sep 30, 2013 −$40.77K